A rapid and systematic review of the clinical effectiveness and cost effectiveness of pegylated liposomal doxorubicin hydrochloride (Caelyx UK, Doxil, USA) for ovarian cancer

C. Forbes, J. Wilby, G. Richardson, L. Mather, M. Sculpher, R. Riemsma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-119
Number of pages119
JournalHealth technology assessment
Issue number23
Publication statusPublished - 2002

Cite this